Boosting T Cell "Memory" May Result in Longer-Lasting and Effective Responses for Patients Treated with Checkpoint Blockade Immunotherapies

Just like people, some T cells have excellent memories. These subtypes known as memory T cells may explain why some immunotherapies are more effective than others and potentially lead to researchers designing more effective studies using combination checkpoint blockade treatments, according to experts at The University of Texas MD Anderson Cancer Center.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News